A former New York State Democratic Party leader, who previously worked for Gov. Andrew Cuomo, has said he received his first dose of the COVID-19 vaccine in Florida due to the slower rollout of inoculations in his native state.
He told the Post he was eligible to receive the COVID-19 shot in Florida as he has been renting an apartment in the state since October 2020. He added that he is due for his second and final dose of the vaccine developed by Pfizer and German firm BioNTech on Feb. 3.
In its first phase, New York’s vaccine rollout prioritized health care workers.
“He was right on. Who’s dying out there? The people 65 and over,” he continued.
“Cuomo’s call to vaccinate seniors came a week later. You know how many people could have been inoculated in a week?” Sullivan added. “Health care workers should be a priority to get the vaccine. But are they a priority over the most vulnerable senior population? Probably not.”
Cuomo said during the briefing that over the next several weeks, the Department of Health will also be setting up 20 mass distribution sites across the state to further the vaccination efforts. Cuomo estimated that it would take around 14 weeks to vaccinate groups 1A and 1B.
Priority group 1A includes workers in health care settings, as well as seniors living in nursing homes and assisted-living facilities. Group 1B includes education workers, first responders, public safety and transit workers, and seniors.
Cuomo said that just over half a million COVID-19 vaccine doses had been administered in New York as of Jan. 8.
“So, 33,000 week one, 102,000 week two, 148,000 week three, 259,000 [week four] to date, but the week is not over,” he said, adding that the state receives a supply of 300,000 doses per week.
“We’re hoping for an acceptance rate close to 80 percent with a minimum of 70 percent.
“The problem all along has been a lack of allocation from Washington, and now that we’ve expanded the population of those eligible, the federal government continues to fail to meet the demand,’ Cuomo spokesman Jack Sterne said in a statement.
Both of the authorized vaccines are built on messenger RNA platforms and require two doses spaced several weeks apart.
“We now believe that our manufacturing is predictable enough that we can ensure second doses are available for people from ongoing production. So everything is now available to our states and our healthcare providers,” Azar told ABC’s “Good Morning America” on Jan. 12.